Discovery and delivery strategies for engineered live biotherapeutic products is a research paper published in Trends in biotechnology (2021). On theSindex it has a DataRank of 0. It has been cited 99 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Novo Nordisk Fonden
Grant: NNF19SA0035474
National Science Foundation
Grant: CBET-1934284
National Institutes of Health
Grant: R35GM137898
National Science Foundation
Grant: 1934284
Design and in situ biomanufacturing of targeted peptide inhibitors via engineered probiotic yeast.
Novo Nordisk Foundation
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R35GM137898-02
Delivery Strategies for Microbe Therapeutics
Fields of Study
Keywords
Sustainable Development Goals